Related Experiment Video
Updated: Dec 21, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Aggrecanopathies highlight the need for genetic evaluation of ISS children
Ola Nilsson1,2
1Division of Pediatric Endocrinology & Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Insights
Genetic testing is identifying specific causes for short stature in children previously diagnosed with idiopathic short stature (ISS). This advances the assessment, counseling, and treatment of non-endocrine growth disorders.
Area of Science:
- Pediatric Endocrinology
- Medical Genetics
- Skeletal Dysplasias
Background:
- Short stature is a common referral reason for pediatric endocrinologists.
- Idiopathic short stature (ISS) is diagnosed when no underlying cause is found, often after extensive evaluation.
- Advances in genetic testing are revealing monogenic causes for ISS.
Purpose of the Study:
- To highlight how genetic discoveries are transforming the understanding and management of short stature.
- To illustrate the impact of identifying specific genetic mutations in children with ISS.
Main Methods:
- Review of recent genetic studies in pediatric short stature cohorts.
- Focus on aggrecan gene mutations (MIM#165800) as an example.
Main Results:
- Genetic methodology has identified specific monogenic conditions within the ISS population.
- Heterozygous aggrecan gene mutations cause isolated short stature and advanced bone age, potentially with osteoarthritis and osteochondritis dissecans.
Conclusions:
- Genetic advancements are crucial for diagnosing previously unexplained short stature.
- Identifying specific genetic causes like aggrecan mutations improves patient assessment, counseling, and treatment strategies for non-endocrine growth disorders.
Abstract:
Short stature is one of the most common causes for referrals to pediatric endocrinologists. However, in a majority of the children, no underlying cause can be identified and the child instead receives the unhelpful diagnosis of idiopathic short stature (ISS), often after extensive work-up and testing. Recent advances in genetic methodology have allowed for the identification of a number of different monogenic conditions within the large cohort of ISS children. Isolated short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans (MIM#165800) due to heterozygous aggrecan gene mutations exemplifies how this progress is changing the way we assess, counsel and treat children with non-endocrine growth disorders.
More Related Videos
06:35A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
Published on: October 10, 2022
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pedigree Analysis
Proteoglycans
Incomplete Dominance
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...